Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-remitting Multiple SclerosisInterventions: Drug: BCD-063; Drug: Copaxone-Teva; Drug: PlaceboSponsor: BiocadCompleted - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2016 Category: Research Source Type: clinical trials
Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)
Conditions: Multiple Sclerosis, Relapsing-Remitting; Relapsing-Remitting Multiple SclerosisIntervention: Drug: dimethyl fumarateSponsor: Biogen IdecNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2014 Category: Research Source Type: clinical trials
Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate
Condition: Multiple SclerosisIntervention: Sponsor: University of Colorado, DenverRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2014 Category: Research Source Type: clinical trials
Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Sponsors: University at Buffalo; TEVAEnrolling by invitation - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2014 Category: Research Source Type: clinical trials
Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)
Condition: Rett SyndromeIntervention: Drug: Glatiramer AcetateSponsors: Montefiore Medical Center; Rett Syndrome Research TrustActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2014 Category: Research Source Type: clinical trials
Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
Condition: Multiple SclerosisIntervention: Sponsors: University at Buffalo; Teva Pharmaceuticals USACompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2013 Category: Research Source Type: clinical trials
Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
Condition: Multiple SclerosisIntervention: Sponsors: University at Buffalo; Teva Pharmaceuticals USANot yet recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2013 Category: Research Source Type: clinical trials
